US Markets End Mixed as Sector Rotation Takes Center Stage

October 21 witnessed a divergent close for major US stock indices, highlighting a clear rotation of investor capital between sectors. The Dow Jones Industrial Average led the gains, rising 1.02%. The S&P 500 edged up 0.29%, while the technology-heavy Nasdaq Composite dipped slightly by 0.02%, essentially flatlining for the session.

Mega-Cap Tech Stocks Face Pressure

A broad sell-off in major technology companies was a key factor capping the Nasdaq's performance.

  • Shares of Apple, Google, and Meta all fell more than 1%.
  • Chipmaker SK Hynix declined over 2%.
  • In a notable exception, Tesla bucked the trend, climbing more than 1%.

This pattern suggests investors may be taking profits in some high-flying tech names following recent gains, shifting focus elsewhere.

Biopharma and GLP-1 Stocks Shine

In stark contrast to tech's weakness, the biopharmaceutical sector surged, with companies linked to weight-loss drugs attracting particularly strong buying interest.

  • Eli Lilly and Amgen jumped more than 3%.
  • AstraZeneca gained nearly 3%.
  • Novo Nordisk and Pfizer also rose over 2%.

The sector's strength was fueled by positive clinical trial updates and robust long-term demand projections for their therapies.

Semiconductors and Energy Sectors Retreat

Meanwhile, semiconductor equipment and materials, along with oil and gas stocks, faced downward pressure.

  • Semiconductor capital equipment firm KLA dropped over 2%, and Applied Materials fell nearly 2%.
  • Lithography leader ASML declined close to 1%.

The sell-off in these more cyclical sectors may reflect growing concerns about the impact of a potential global economic slowdown on end-demand, prompting a flight to more defensive areas like healthcare.

This week's trading action underscores a significant sector rotation at play. Money appears to be moving out of select technology and cyclical segments and into perceived safer havens like biopharma. This dynamic is likely to continue influencing market direction in the near term.